Abbott Laboratories (ABT)vsMolson Coors Brewing Co Class B (TAP)
ABT
Abbott Laboratories
$84.32
-3.09%
HEALTHCARE · Cap: $151.56B
TAP
Molson Coors Brewing Co Class B
$42.41
-1.67%
CONSUMER DEFENSIVE · Cap: $8.09B
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 303% more annual revenue ($45.13B vs $11.19B). ABT leads profitability with a 13.9% profit margin vs -18.9%. ABT appears more attractively valued with a PEG of 1.29. TAP earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy56
out of 100
Grade: C
TAP
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+0.6%
Fair Value
$87.53
Current Price
$84.32
$3.21 discount
Margin of Safety
+59.8%
Fair Value
$132.44
Current Price
$42.41
$90.03 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Reasonable price relative to book value
Earnings expanding 35.6% YoY
Areas to Watch
Weak financial health signals
Earnings declined 19.7%
2.0% revenue growth
Expensive relative to growth rate
ROE of -18.1% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bull Case : TAP
The strongest argument for TAP centers on Price/Book, EPS Growth.
Bear Case : ABT
The primary concerns for ABT are Piotroski F-Score, EPS Growth.
Bear Case : TAP
The primary concerns for TAP are Revenue Growth, PEG Ratio, Return on Equity.
Key Dynamics to Monitor
ABT profiles as a value stock while TAP is a turnaround play — different risk/reward profiles.
ABT carries more volatility with a beta of 0.65 — expect wider price swings.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
ABT scores higher overall (56/100 vs 56/100). TAP offers better value entry with a 59.8% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Molson Coors Brewing Co Class B
CONSUMER DEFENSIVE · BEVERAGES - BREWERS · USA
The Molson Coors Beverage Company, commonly known as Molson Coors, is a multinational drink and brewing company headquartered in Chicago in the United States.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?